血清基质金属蛋白酶8与金属蛋白酶组织抑制因子1:复发性呼吸道乳头状瘤恶变及喉癌预后的潜在标志物
该研究检测114例患者(55例复发性呼吸道乳头状瘤,59例无既往复发性呼吸道乳头状瘤的喉鳞状细胞癌)的血清基质金属蛋白酶8和金属蛋白酶组织抑制因子1。复发性呼吸道乳头状瘤中血清基质金属蛋白酶8升高与恶变相关(P=0.01),喉鳞状细胞癌中血清金属蛋白酶组织抑制因子1升高与总生存期(P=0.02)和无复发生存期(P=0.05)不良相关。
要点
- 复发性呼吸道乳头状瘤中血清基质金属蛋白酶8升高与恶变相关(P=0.01)。
- 喉鳞状细胞癌患者血清基质金属蛋白酶8显著高于复发性呼吸道乳头状瘤患者(P<0.001)。
- 喉鳞状细胞癌中血清金属蛋白酶组织抑制因子1升高与总生存期(P=0.02)和无复发生存期(P=0.05)不良相关。
核心结论
- 复发性呼吸道乳头状瘤中高血清基质金属蛋白酶8可能预测恶变。
- 喉鳞状细胞癌中血清金属蛋白酶组织抑制因子1升高与生存不良相关。
研究设计与样本
- 研究分析114例患者,其中55例因复发性呼吸道乳头状瘤治疗,59例因无既往复发性呼吸道乳头状瘤的喉鳞状细胞癌治疗。
- 复发性呼吸道乳头状瘤患者中5例在随访期间发生喉鳞状细胞癌。
主要发现
- 复发性呼吸道乳头状瘤中血清基质金属蛋白酶8升高与恶变相关(P=0.01)。
- 与复发性呼吸道乳头状瘤患者相比,喉鳞状细胞癌患者血清基质金属蛋白酶8显著更高(P<0.001)。
- 喉鳞状细胞癌中血清金属蛋白酶组织抑制因子1升高与总生存期不良相关(P=0.02)。
- 喉鳞状细胞癌中血清金属蛋白酶组织抑制因子1升高与无复发生存期不良相关(P=0.05)。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Biomarkers that could predict malignant transformation of recurrent respiratory papillomatosis (RRP) would be useful in patient follow-up. We investigated whether serum matrix metalloproteinase 8 (MMP-8) and tissue inhibitor of metalloproteinase 1 (TIMP-1) could predict malignant transformation of RRP and whether they associate with survival in laryngeal squamous cell carcinoma (LSCC) without preexisting RRP. METHODS: We analyzed serum MMP-8 (S-MMP-8) and serum TIMP-1 (s-TIMP-1) in 114 patients: 55 were treated for RRP and 59 for LSCC without preexisting RRP. Five patients with RRP developed LSCC during follow-up. RESULTS: Elevated S-MMP-8 level in RRP was associated with malignant transformation (P = .01). Compared to patients with RRP, S-MMP-8 in patients with LSCC was significantly higher (P < .001). Increased S-TIMP-1 level in LSCC was associated with poor overall survival (P = .02) and recurrence-free survival (P = .05). CONCLUSION: In RRP, high S-MMP-8 may predict malignant transformation. In LSCC, elevated S-TIMP-1 is connected to poor survival.
引用
- Pakkanen PP, Aaltonen LM, Sorsa TA, et al. Serum matrix metalloproteinase 8 and tissue inhibitor of metalloproteinase 1: Potential markers for malignant transformation of recurrent respiratory papillomatosis and for prognosis of laryngeal cancer. Head Neck. 2018. PMID: 30549356. doi:10.1002/hed.25459
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。